Rchr
J-GLOBAL ID:200901074437174999   Update date: Sep. 29, 2024

Inamoto Teruo

Inamoto Teruo
Affiliation and department:
Job title: Professor
Research field  (4): Urology ,  Tumor diagnostics and therapeutics ,  Nephrology ,  Urology
Research keywords  (2): hinotori cockpit surgeon ,  Da Vinci surgery
Research theme for competitive and other funds  (9):
  • 2024 - 2029 副腎皮質癌の免疫逃避において機能欠損型ZNFR3が来す役割の解明
  • 2021 - 2026 Therapeutic effect of boron neutron supplementation therapy with PDL1 antibody for advanced bladder cancer (including metastasis)
  • 2020 - 2024 変異SETD2の機能喪失メカニズムの解析と腎癌に対する免疫療法への応用
  • 2016 - 2021 The novel bladder preservation therapy by selective destruction of cancercells "Boron Neutron Capture Therapy at bladder"
  • 2016 - 2020 Therapy for bladder cancer by means of a novel delivery carrier for miR-145
Show all
Papers (232):
  • Kazuki Nishimura, Kiyoshi Takahara, Kazumasa Komura, Mitsuaki Ishida, Kensuke Hirosuna, Ryoichi Maenosono, Masahiko Ajiro, Moritoshi Sakamoto, Kengo Iwatsuki, Yuki Nakajima, et al. Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma. NPJ precision oncology. 2024. 8. 1. 206-206
  • Taizo Uchimoto, Takuya Matsuda, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Mamoru Hashimoto, et al. C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma. Targeted oncology. 2024. 19. 4. 635-644
  • Taizo Uchimoto, Shuya Tsuchida, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Mamoru Hashimoto, et al. Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors. Targeted oncology. 2024. 19. 3. 401-410
  • Hajime Hirano, Yuya Fujiwara, Tomota Okabe, Keita Nakamori, Koichiro Minami, Hirofumi Uehara, Hayahito Nomi, Kazumasa Komura, Teruo Inamoto, Haruhito Azuma. Importance of Management of Lifestyle-Related Diseases After Kidney Donation to Living Donors. Transplantation proceedings. 2024. 56. 3. 479-481
  • Takuhisa Nukaya, Kiyoshi Takahara, Atsuhiko Yoshizawa, Masanobu Saruta, Yusuke Yano, Takaya Ohno, Taizo Uchimoto, Wataru Fukuokaya, Takahiro Adachi, Shogo Yamazaki, et al. Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study. Clinical genitourinary cancer. 2024. 22. 1. 76-83
more...
MISC (515):
  • Kazuki Nishimura, Kazumasa Komura, Kensuke Hirosuna, Mitsuaki Ishida, Teruo Inamoto, Haruhito Azuma, Akihide Yoshimi. A comprehensive multi-omics analysis exploring the correlation between NECTIN4 and tumor microenvironment profiles in bladder cancer. JCO Global Oncology. 2023. 2023. 9. 74-74
  • 能見勇人, 能見勇人, 中森啓太, 岡部知太, 山崎捷悟, 徳重敏, 大野貴也, 寺本昌司, 寺本昌司, 南幸一郎, et al. Correlation between preoperative aortic calcification index and renal transplant prognosis of the recipients in our institution. 日本泌尿器科学会総会(Web). 2023. 110th
  • 福島龍生, 前之園良一, 能見勇人, 藤原裕也, 上原博史, 平野一, 稲元輝生, 東治人, 松村英樹, 芦田明, et al. LMX1B遺伝子変異を認めないNPLRDに対して生体腎移植を施行した1例. 泌尿器科紀要. 2023. 69. 12
  • Teruo Inamoto, Haruhito Azuma. Editorial Comment to Day-case catheterless and drainless minimal-access pyeloplasty in adults: A single-center experience of 13 years. International Journal of Urology. 2021. 28. 5. 518-519
  • 柳原一隆, 内本泰三, 福岡屋航, 上原博史, 小村和正, 平野一, 能見勇人, 稲元輝生, 木村高弘, 穎川晋, et al. Pembrolizumab投与した転移性尿路上皮癌における6week後Objective response rate(ORR)とNLR変化の検討. 日本泌尿器科学会中部総会プログラム・抄録集. 2021. 71st
more...
Patents (2):
Work history (2):
  • 2006/11 - 2008/03 M.D. Anderson Cancer Center
  • 2004/04 - 2006/10 The University of Tokyo The Institute of Medical Science
Committee career (9):
  • 2018/04 - 現在 日本泌尿器科学会 専門医資格試験口答試験部会員
  • 2016/02 - 現在 日本泌尿器癌局所療法研究会 世話人
  • 2016/02 - 現在 日本泌尿器科学会 関西地方会 運営委員
  • 2015/04 - 現在 日本アンドロロジー学会 評議員
  • 2015/04 - 現在 泌尿器内視鏡学会 評議員
Show all
Awards (22):
  • 2018/10 - 日本泌尿器科学会 第68回 中部総会 優秀演題賞
  • 2017/08 - Urologic Oncology; Outstanding Contribution in Reviewing
  • 2017/05 - American Urological Asssociation 2017 Annual Meeting - Best Poster
  • 2017/04 - 日本泌尿器科学会 第105回総会 総会賞
  • 2016/08 - CSCO 19th CSCO travel award
Show all
Association Membership(s) (10):
性機能学会 ,  日本泌尿器科学会西日本支部 ,  Webmed central-UK(Lead Faculty in WMC urology faculty ,  大阪泌尿器臨床医会 ,  日本泌尿器科分子・細胞研究会 ,  American Urological Association ,  日本癌治療学会 ,  日本泌尿器科内視鏡学会 ,  日本内視鏡外科学会 ,  日本泌尿器科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page